Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Drug Metabolism: Phase I Reactions
Prochirality
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
Chirality in Nature
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 23, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Thomas Lautier1, Philippe Urban1, Jacqueline Loeper2
1Université de Toulouse, INSA, UPS, INP, LISBP, 135 Avenue de Rangueil, F-31077 Toulouse, France; INRA, UMR792 Ingénierie des Systèmes Biologiques et des Procédés, F-31400 Toulouse, France; CNRS, UMR5504, 135 Avenue de Rangueil, F-31400 Toulouse, France.
Specific sequence segments in CYP2B enzymes precisely control substrate affinity shifts. Swapping elements between CYP2B6 and CYP2B11 reveals key structural determinants of enzyme function and plasticity.
07:38A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: